Market Expansion Potential Valeant's diversified portfolio and recent acquisitions, such as Bausch + Lomb and AcneFree, demonstrate ongoing growth and market expansion, presenting sales opportunities in ophthalmology, dermatology, and consumer health segments.

Regulatory and Ethical Challenges The company's history of legal issues including bribery charges and deceptive practices suggests a need for providers of compliant, transparent solutions and consulting services that can support improved corporate governance and ethical standards.

Innovation and Product Launches Recent market introduction of products like flibanserin (Addyi) after strategic acquisitions indicates openness to innovative therapies, providing opportunities to pitch new formulations, complementary medications, or research collaborations.

Technology and Data Analytics Utilizing digital tools such as Google Analytics and ASP.NET shows a focus on technology; offering advanced data solutions or digital marketing services could enhance Valeant’s market reach and operational efficiency.

Large Employee Base With over 1,000 employees in the US, there are significant opportunities to engage multiple departments such as R&D, manufacturing, and compliance with tailored B2B solutions, training, or supply chain support to streamline their operations.